Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Advanced Ovarian Cancer and Sexuality Phase 1
Phase 1 clinical trial from the University of British Columbia evaluating advanced ovarian cancer and sexuality has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer [NA]
Completed efficacy trial evaluating FloSeal for prevention of lymphocele after lymphadenectomy in gynecologic cancer.
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
Clinical trial update notes neutropenia observed in patients with epithelial ovarian cancer receiving adjuvant paclitaxel/carboplatin chemot…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer [Phase 2]
The update notes that a Phase 2 efficacy study evaluating neoadjuvant chemotherapy for advanced ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of RO4929097 in recurrent/metastatic epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: BMN 673 (Talazoparib), an Oral PARP Inhibitor, in People With Deleterious BRCA1/2 Mutation-Associated Ovarian Cancer Who Have Had Prior PARP Inhibitor Treatment [Phase 2]
Phase 2 trial evaluating BMN 673 (talazoparib), an oral PARP inhibitor, in ovarian cancer patients with deleterious BRCA1/2 mutations who pr…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma [Phase 2]
A Phase 2 feasibility trial evaluating intraperitoneal chemotherapy for ovarian, fallopian tube, and primary peritoneal carcinomas has been …
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer [Phase 1]
This is a completed Phase I/Ib trial evaluating paclitaxel in combination with VS-6063 (defactinib) in patients with advanced ovarian cancer…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating bevacizumab in patients with ovarian cancer or primary perit…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625) [Phase 2]
A Phase 2 study evaluating the safety and efficacy of Caelyx in combination with carboplatin in patients with ovarian cancer that recurs wit…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites [Phase 2]
Phase 2 study of AZD9150 (danvatirsen), a STAT3 antisense oligonucleotide, in patients with malignant ascites associated with ovarian or gas…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: A Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin® Compared to Genexol® Plus Carboplatin® as a Firstline Treatment in Subjects With Ovarian Cancer [Phase 2]
A Phase 2 randomized trial evaluating efficacy and safety of Genexol-PM plus carboplatin versus Genexol plus carboplatin as first-line treat…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 3]
A Phase 3 trial of moxifloxacin to prevent bacterial infections in patients who have undergone a donor stem cell transplant was terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: ROGYcare: The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers [NA]
A completed clinical trial (ROGYcare) evaluating the impact of a cancer survivorship care plan on patient-reported outcomes and health care …
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial results for GM-CSF (sargramostim) in women with recurrent ovarian cancer (including fallopian tube cancer) have been …
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer [Phase 2]
Phase 2 trial evaluating Temsirolimus, Carboplatin, and Paclitaxel as first-line therapy for newly diagnosed stage III-IV clear cell ovarian…
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer [Phase 1]
A Phase 1 trial of an ImmunoVaccine Technologies cancer vaccine for advanced ovarian cancer, fallopian tube cancer, or peritoneal cancer has…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary [Phase 1]
A Phase 1 clinical trial evaluating contrast-enhanced ultrasonography to diagnose early-stage ovarian cancer in women with an adnexal mass u…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Ensuring Communication in Hospice by Oncology Study (ECHO) [NA]
The ECHO hospice communication trial, sponsored by Massachusetts General Hospital, has completed and involved patients with ovarian, cervica…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Intraperitoneal Chemotherapy Alone or in Combination With Bevacizumab for Ovarian Cancer With Peritoneal Adhesion [Phase 2]
Phase 2 clinical trial update examining intraperitoneal chemotherapy with or without bevacizumab for ovarian cancer with peritoneal adhesion…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma [Phase 1, Phase 2]
A phase 1/2 trial of paclitaxel, carboplatin, and vorinostat for advanced ovarian cancer was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer [Phase 2]
Phase 2 trial investigating pimasertib with SAR245409 or placebo in ovarian cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors [NA]
The clinical trial update notes completion of a cognitive-behavioral intervention designed to help cancer survivors manage worry, uncertaint…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer [Phase 2]
Phase 2 trial of MORAb-003 (farletuzumab) in platinum-resistant or refractory relapsed ovarian cancer was terminated, with results posted in…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors [Phase 1]
Phase 1 study by MedImmune evaluating safety and antitumor activity in adults with advanced solid tumors, including advanced recurrent ovari…